Sodium zirconium cyclosilicate reconciles management of hyperkalemia and continuity of renin–angiotensin–aldosterone system inhibitors: a retrospective observational study-Reference-Cited by-同舟云学术

Sodium zirconium cyclosilicate reconciles management of hyperkalemia and continuity of renin–angiotensin–aldosterone system inhibitors: a retrospective observational study

Published:2023-08-22 Issue: Volume: Page:
ISSN:1724-6059
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Kimura Wakana,Minatoguchi Shun^ORCID,Mizuno Tomohiro,Koide Shigehisa,Hayashi Hiroki,Hasegawa Midori,Inaguma Daijo,Tsuboi Naotake

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s40620-023-01743-4.pdf

Reference29 articles.

1. Hill NR, Fatoba ST, Oke JL et al (2016) Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS ONE 11:e0158765

2. Grams ME, Chow EKH, Segev DL, Coresh J (2013) Lifetime incidence of CKD stages 3–5 in the United States. Am J Kidney Dis 62:245–252

3. Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 3:1–150

4. Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med 345:861–869

5. Xie X, Liu Y, Perkovic V et al (2016) Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials. Am J Kidney Dis 67:728–741

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing crush syndrome management: the potent role of Sodium zirconium cyclosilicate in early hyperkalemia intervention and survival enhancement in a rat model;Frontiers in Pharmacology;2024-05-13